Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

20122,851 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 381, Issue 9863, pp. 303-312

Field-Weighted Citation Impact: 85.72